These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24699039)

  • 1. Acute pancreatitis associated with quetiapine use in schizophrenia.
    Chang TG; Chiu NY; Hsu WY
    J Clin Psychopharmacol; 2014 Jun; 34(3):382-3. PubMed ID: 24699039
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose loading with extended release quetiapine.
    Chae BJ
    J Clin Pharm Ther; 2010 Aug; 35(4):487-9. PubMed ID: 20831551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044
    [No Abstract]   [Full Text] [Related]  

  • 6. Quetiapine: a new atypical antipsychotic for the treatment of schizophrenia.
    Gray R
    Ment Health Care; 1998 Jan; 1(5):163-4. PubMed ID: 9791402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
    Beszłej JA; Grzesiak M
    Psychiatr Pol; 2005; 39(2):293-307. PubMed ID: 15881624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal quetiapine abuse.
    Pierre JM; Shnayder I; Wirshing DA; Wirshing WC
    Am J Psychiatry; 2004 Sep; 161(9):1718. PubMed ID: 15337673
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolactin elevation with quetiapine.
    Alexiadis M; Whitehorn D; Woodley H; Kopala L
    Am J Psychiatry; 2002 Sep; 159(9):1608-9. PubMed ID: 12202292
    [No Abstract]   [Full Text] [Related]  

  • 10. Quetiapine-induced myoclonus.
    Velayudhan L; Kirchner V
    Int Clin Psychopharmacol; 2005 Mar; 20(2):119-20. PubMed ID: 15729090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies.
    Meulien D; Huizar K; Brecher M
    Hum Psychopharmacol; 2010 Mar; 25(2):103-15. PubMed ID: 20196185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.
    Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H;
    J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine-induced leucopenia: possible dosage-related phenomenon.
    Oluboka O; Haslam D; Lam T; Bown-Demarco D
    Can J Psychiatry; 2003 Feb; 48(1):65-6. PubMed ID: 12635569
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of quetiapine fumarate extended release in the treatment of Korean patients with acute schizophrenia.
    Lee JG; Lee JI; Kim YT; Kim CE; Kim CY; Yoon JS; Yoo SY; Kim YH
    Hum Psychopharmacol; 2012 Jul; 27(4):403-10. PubMed ID: 22753400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
    Leweke FM; Gerth CW; Koethe D; Nolden BM; Klosterkötter J
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study.
    Boidi G; Ferro M
    Hum Psychopharmacol; 2007 Jul; 22(5):299-306. PubMed ID: 17487936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned.
    Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D
    Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of Seroquel in schizophrenia].
    Chakhava VO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):63-4. PubMed ID: 11026140
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine-associated acute dystonia.
    Kropp S; Hauser U; Ziegenbein M
    Ann Pharmacother; 2004 Apr; 38(4):719-20. PubMed ID: 14966260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.